GlassScriptPhysician profile
Debora Ann Goodrich
NPI 1245325968
$3,817.53
in general payments reported to CMS, 2019-2025
31 companies · $1,073 in 2025
The $1,073 reported for 2025 was more than what 86% of Internal Medicine providers received nationally (typical 2025 total: $156).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $234 · 2020: $198 · 2021: $243 · 2022: $459 · 2023: $790 · 2024: $822 · 2025: $1,073.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,684.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,684.38 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $484.50 | 2019-2025 | |
| Novo Nordisk INC | $386.72 | 2019-2025 | Rybelsus, Ozempic, Wegovy |
| Otsuka America Pharmaceutical, INC. | $298.58 | 2022-2025 | Rexulti |
| Astrazeneca Pharmaceuticals LP | $284.00 | 2019-2025 | Farxiga, Breztri, Airsupra |
| Dexcom, INC. | $278.52 | 2022-2025 | Dexcom G6 Transmitter |
| Glaxosmithkline, LLC. | $237.08 | 2019-2025 | Trelegy Ellipta, Arexvy, Shingrix |
| Boehringer Ingelheim Pharmaceuticals, INC. | $230.86 | 2019-2025 | Jardiance, Ofev, Synjardy |
| Lilly USA, LLC | $217.71 | 2019-2025 | Jardiance, Mounjaro, Emgality |
| Pfizer INC. | $196.16 | 2019-2025 | |
| Bayer Healthcare Pharmaceuticals INC. | $139.77 | 2021-2024 | |
| Amgen INC. | $121.98 | 2019-2025 | Otezla, Repatha |
| Merck Sharp & Dohme LLC | $91.49 | 2020-2023 | Belsomra, Steglatro |
| Abbott Laboratories | $83.04 | 2023-2025 | Freestyle Libre 3 |
| Lundbeck LLC | $83.04 | 2023-2025 | Rexulti |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $79.22 | 2019-2025 | Xifaxan, Relistor |
Show all 31 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phathom Pharmaceuticals, INC. | $60.56 | 2024-2025 | Voquezna |
| Sanofi-Aventis U.S. LLC | $59.46 | 2024-2025 | |
| Iti, INC. (D/B/A Intra-Cellular Therapies, INC.) | $57.57 | 2025 | Caplyta |
| Janssen Pharmaceuticals, INC | $56.69 | 2020-2021 | |
| Exact Sciences Corporation | $50.28 | 2023-2024 | Cologuard Collection Kit |
| Novartis Pharmaceuticals Corporation | $49.38 | 2022-2023 | |
| Shield Therapeutics INC | $48.08 | 2024-2025 | |
| Xeris Pharmaceuticals, INC. | $46.40 | 2023 | Gvoke Hypopen |
| Mylan Specialty L.P. | $33.03 | 2022 | |
| Boston Scientific Corporation | $32.09 | 2025 | General - Pain Management |
| Allergan, INC. | $25.16 | 2020 | |
| Axsome Therapeutics, INC. | $20.41 | 2025 | Auvelity |
| Sanofi Pasteur INC. | $19.97 | 2025 | |
| Inspire Medical Systems, INC. | $18.11 | 2025 | Inspire |
| Teva Pharmaceuticals USA, INC. | $14.89 | 2025 | Austedo Xr |
| Idorsia Pharmaceuticals US INC | $12.78 | 2023 | Quviviq |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Debora Goodrich listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.